MAPK3 and neoplasm: Previous studies have demonstrated that immunoglobulin-like transcript 4, an immunosuppressive molecule expressed in tumor cells, can activate the MAPK-ERK1/2 signaling pathway to enhance FA synthesis and lipid accumulation in tumor cells, thereby inducing effector T cell senescence and inhibiting specific T cell senescence expression.